FENCF

 
Ordinary Shares SEC Reporting - Current
OTCQB
Verified Company Profile 4/05/2017
Contact Info
  • 68 T W Alexander Drive
  • PO Box 13628
  • Research Triangle Pa, NC 27709

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001211583
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1996
Employees 3 a/o Mar 31, 2017
Company Officers/Contacts
Rostislav Raykov CEO
Robert Andrade CFO
Mark Gowland Controller
Company Directors
Khalid Islam Chairman, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Marco Brughera Compensation Committee Member, Nominating Committee Member
Adrian Haigh Audit Committee Member, Nominating Committee Member
Chris A. Rallis Audit Committee Member, Compensation Committee Member
Rostislav Raykov
Service Providers
Accounting/Auditing Firm
Deloitte & Touche LLP
225 W. Santa Clara St.
San Jose, CA, 95113
United States
 
Securities Counsel
LeBarge Weinstein
515 Legget Drive
Suite 800
Ottawa, ONT, K2K 3G4
Canada
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Adherex Technologies Inc. until 9-2014
  • Note=9-30-04 company is in the development stage
FENCF Security Details
Share Structure
Market Value1 $68,810,676 a/o Jun 23, 2017
Authorized Shares Unlimited a/o Mar 31, 2017
Outstanding Shares 13,707,306 a/o May 12, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 51 a/o Feb 28, 2017
Non US Stock Exchange Listing
FRX - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 501 (4,075%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security